MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 234 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $245,090 | -98.6% | 24,509 | -98.3% | 0.00% | -100.0% |
| Q2 2023 | $18,138,665 | +358.5% | 1,459,265 | +416.8% | 0.01% | +400.0% |
| Q1 2023 | $3,955,724 | +264.6% | 282,350 | +272.4% | 0.00% | +100.0% |
| Q4 2022 | $1,085,013 | +600.0% | 75,822 | +1150.4% | 0.00% | – |
| Q3 2022 | $155,000 | -6.6% | 6,064 | +3.9% | 0.00% | – |
| Q2 2022 | $166,000 | +1.8% | 5,837 | +26.6% | 0.00% | – |
| Q1 2022 | $163,000 | -83.7% | 4,610 | -80.7% | 0.00% | – |
| Q4 2021 | $1,000,000 | -97.3% | 23,864 | -96.9% | 0.00% | -100.0% |
| Q3 2021 | $37,436,000 | +1116.6% | 762,757 | +934.4% | 0.02% | +1700.0% |
| Q2 2021 | $3,077,000 | -10.0% | 73,742 | -23.1% | 0.00% | -50.0% |
| Q1 2021 | $3,418,000 | +125.9% | 95,858 | +77.7% | 0.00% | +100.0% |
| Q4 2020 | $1,513,000 | – | 53,949 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |